RecruitingNCT06458764

Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Sectional Study

SEXCHECK - Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Sectional Study


Sponsor

Candiolo Cancer Institute - IRCCS

Enrollment

150 participants

Start Date

May 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Primary objectives: * To estimate Sexual Dysfunction (SD) incidence in premenopausal breast cancer patients treated by surgery and taking endocrine therapy. * To detect the presence of SD-related distress in the population, as a determining factor in the maintenance of a good quality of life. Secondary objectives: * To describe SD characteristics determining the most frequently reported symptoms and correlations with type of surgery or therapeutic regimens. * Collect baseline data for subsequent randomized trials involving practical interventions with the aim to reduce SD prevalence in this population.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This study is a survey-based investigation examining sexual dysfunction in premenopausal women who have survived early-stage breast cancer and are currently on hormone-blocking therapy (endocrine therapy). The goal is to understand how common these side effects are and how they affect quality of life. **You may be eligible if...** - You are a woman between 18 and 55 years old - You had surgery for early-stage breast cancer - You have been on endocrine therapy (hormone-blocking medication) for at least 3 months - You can provide informed consent and complete the questionnaires **You may NOT be eligible if...** - You withdraw your consent at any time Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQuestionnaire

none, it's a incidence-prevalence study


Locations(1)

IRCCS Candiolo Cancer Center

Torino, TO, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06458764


Related Trials